Literature DB >> 7762277

Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations.

F Stieneker1, G Kersten, L van Bloois, D J Crommelin, S L Hem, J Löwer, J Kreuter.   

Abstract

The objective of this study was the comparison of the quantity and quality of the humoral immune response against inactivated whole human immunodeficiency virus type 2. Twenty-four different adjuvants were tested. The toxicity of these preparations was determined. Due to the large number of experiments, the animal model used was the NMRI mouse. Sera were assayed for the presence of antibodies by ELISA and Western blot. The toxicity of the adjuvants was determined by observing lethal side-effects occurring within two days after injection of the immunogenic preparations. The results show that polymethylmethacrylate nanoprticles were the best overall adjuvant, inducing the highest titres of antibodies compared with other adjuvants as well as producing a significantly better immune response against a number of individual HIV-2 antigens without any observable toxic side-effects. However, this adjuvant did not induce antibodies against the outer envelope protein gp120, whereas such antibodies were induced by aluminium compounds, Freund's complete and incomplete adjuvants, and fumed silica (Aerosil). This result suggests the necessity of using vaccines with two or more different adjuvants in order to induce the required immune response against physically different antigens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762277     DOI: 10.1016/0264-410x(95)80010-b

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.

Authors:  Neil C Robson; Helen Beacock-Sharp; Anne M Donachie; Allan McI Mowat
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

2.  Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major.

Authors:  Somayeh Zarrati; Mehdi Mahdavi; Fatemeh Tabatabaie
Journal:  J Parasit Dis       Date:  2014-08-31

3.  Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis.

Authors:  Jai-Wei Lee; Celia N O'Brien; Albert J Guidry; Max J Paape; Kimberley A Shafer-Weaver; X Zhao
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

Review 4.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

Review 5.  Modulation of HIV-1 immunity by adjuvants.

Authors:  M Anthony Moody
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

6.  Induction of Immune Responses by DNA Vaccines Formulated with Dendrimer and Poly (Methyl Methacrylate) (PMMA) Nano-Adjuvants in BALB/c Mice Infected with Leishmania major.

Authors:  Fatemeh Tabatabaie; Nasim Samarghandi; Somayeh Zarrati; Fatemeh Maleki; Mehdi Shafiee Ardestani; Taher Elmi; Sayed Hussain Mosawi
Journal:  Open Access Maced J Med Sci       Date:  2018-01-27

Review 7.  Vaccine delivery using nanoparticles.

Authors:  Anthony E Gregory; Richard Titball; Diane Williamson
Journal:  Front Cell Infect Microbiol       Date:  2013-03-25       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.